Challenges in Clinical Research in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Challenges in Clinical Research in Brazil

Challenges in Clinical Research in Brazil – CRO Partner

Clinical research is a vital component of the healthcare landscape, driving medical advancements and improving patient care. In Brazil, a nation known for its diverse culture and evolving healthcare system, clinical research holds great potential. However, it also faces a range of challenges.

This blog will delve into some of the key hurdles encountered in conducting clinical research in Brazil and explore the efforts being made to overcome them.

Regulatory Complexity

One of the primary challenges in clinical research in Brazil is the intricate regulatory landscape. The National Health Surveillance Agency (ANVISA) and the National Research Ethics Committee (CONEP) are responsible for regulating clinical trials and research. Navigating the regulatory requirements can be a time-consuming process, involving extensive documentation and approvals that often result in delays in study initiation.

Furthermore, regulations can vary among regions and institutions, leading to inconsistencies and confusion. Streamlining these processes and harmonizing guidelines would greatly enhance the efficiency of clinical research in Brazil.

Limited Research Infrastructure

Brazil faces a shortage of research infrastructure, including clinical trial sites, research laboratories, and trained research personnel. The lack of well-equipped facilities and experienced staff can hinder the timely execution of trials and limit the scope of research activities. Investment in research infrastructure and educational programs to cultivate a skilled workforce are essential to address this challenge.

Patient Recruitment and Diversity

Recruiting suitable participants for clinical trials is often a significant hurdle in Brazil. To ensure that research findings are applicable to a broad population, a more extensive and diverse pool of volunteers is necessary. Building trust within communities, educating potential participants about the importance of clinical trials, and addressing cultural factors influencing participation can improve recruitment rates.

Socioeconomic Factors

Socioeconomic disparities in Brazil can affect access to healthcare and participation in clinical research. Many individuals from marginalized communities may lack the resources or information to engage in clinical trials. Initiatives aimed at reducing these disparities through targeted outreach, community engagement, and financial incentives can help mitigate this challenge.

Data Management and Transparency

Effective data management and transparency are fundamental to conducting high-quality clinical research. Brazil can benefit from improved data collection, storage, and sharing practices. Ensuring data security, safeguarding patient privacy, and promoting transparency in research outcomes are areas that require attention and investment.

Challenges in Clinical Research in Brazil

Challenges in Clinical Research in Brazil

Challenges in Clinical Research in Brazil

Collaboration and Funding

Collaboration between academia, government agencies, and the private sector is essential for advancing clinical research. However, fostering such collaborations can be challenging due to differing priorities and competition for limited funding. Encouraging public-private partnerships and increasing research funding can help overcome these barriers.

Cultural and Linguistic Sensitivity

Brazil’s diverse population includes various indigenous communities and linguistic groups. To ensure that clinical research is culturally sensitive and accessible to all, translating consent forms and study materials into local languages and engaging community leaders are crucial steps. Building trust and inclusivity within these communities is paramount.

Intellectual Property Rights

Intellectual property rights can be a contentious issue in clinical research, particularly concerning data ownership and patent protection. Clear regulations and agreements are essential to fostering innovation while safeguarding the interests of all stakeholders.

Ethical Considerations

Ethical considerations in clinical research are of utmost importance. Researchers in Brazil must adhere to strict ethical guidelines and obtain informed consent from participants. Addressing ethical issues related to vulnerable populations, such as minors or individuals with limited decision-making capacity, requires careful consideration and protection.

Public Awareness and Education

Finally, raising public awareness about the importance of clinical research and its potential benefits is an ongoing challenge. Public outreach campaigns, educational programs, and community engagement efforts can help improve understanding and garner support for clinical research endeavors.


Brazil, with its diverse culture and evolving healthcare system, is well-positioned to contribute significantly to global clinical research efforts. However, this potential is accompanied by a set of challenges, from regulatory complexity and limited infrastructure to patient recruitment and ethical considerations.

Through collaborative efforts involving government agencies, healthcare institutions, researchers, and the private sector, Brazil can overcome these obstacles and establish itself as a thriving hub for clinical research.

By addressing these challenges proactively, Brazil can play a pivotal role in advancing medical knowledge, improving patient care, and fostering innovation in healthcare for its citizens and the global community.

Challenges in Clinical Research in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Challenges in Clinical Research in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Challenges in Clinical Research in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Challenges in Clinical Research in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Challenges in Clinical Research in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Challenges in Clinical Research in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Challenges in Clinical Research in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Challenges in Clinical Research in Brazil

The Cohortias Team

Challenges in Clinical Research in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Challenges in Clinical Research in Brazil

Network & Partnerships